{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:13:17Z","timestamp":1794507197944,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09541"],"award-info":[{"award-number":["22K09541"]}],"id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09634"],"award-info":[{"award-number":["22K09634"]}],"id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer-testis antigens (CTAs) are often expressed in tumor and testicular tissues but not in other normal tissues. To date, there has been no comprehensive study of the expression and clinical significance of CTA genes associated with endometrial cancer (EC) development. Additionally, the clinical relevance, biological role, and molecular mechanisms of the CTA gene TTK protein kinase (<jats:italic>TTK<\/jats:italic>) in EC are yet to be fully understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using bioinformatics methods, we comprehensively investigated the genomic, transcriptomic, and epigenetic changes associated with aberrant TTK overexpression in EC samples from the TCGA database. We further investigated the mechanisms of the lower survival associated with TTK dysregulation using single-cell data of EC samples from the GEO database. Cell functional assays were used to confirm the biological roles of TTK in EC cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 80 CTA genes that were more abundant in EC than in normal tissues, and high expression of <jats:italic>TTK<\/jats:italic> was significantly linked with lower survival in EC patients. Furthermore, ROC analysis revealed that TTK could accurately distinguish stage I EC tissues from benign endometrial samples, suggesting that TTK has the potential to be a biomarker for early EC detection. We found <jats:italic>TTK<\/jats:italic> overexpression was more prevalent in EC patients with high-grade, advanced tumors, serous carcinoma, and <jats:italic>TP53<\/jats:italic> alterations. Furthermore, in EC tissue, TTK expression showed a strong positive correlation with EMT-related genes. With single-cell transcriptome data, we identified a proliferative cell subpopulation with high expression of TTK and known epithelial\u2013mesenchymal transition (EMT)-related genes and transcription factors. When proliferative cells were grouped according to <jats:italic>TTK<\/jats:italic> expression levels, the overexpressed genes in the TTK<jats:sup>high<\/jats:sup> group were shown to be functionally involved in the control of chemoresistance. Utilizing shRNA to repress TTK expression in EC cells resulted in substantial decreases in cell proliferation, invasion, EMT, and chemoresistance. Further research identified microRNA-21 (miR-21) as a key downstream regulator of TTK-induced EMT and chemoresistance. Finally, the TTK inhibitor AZ3146 was effective in reducing EC cell growth and invasion and enhancing the apoptosis of EC cells generated by paclitaxel.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings establish the clinical significance of TTK as a new biomarker for EC and an as-yet-unknown carcinogenic function. This present study proposes that the therapeutic targeting of TTK might provide a viable approach for the treatment of EC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-03998-8","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T03:02:17Z","timestamp":1677294137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Yu","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyue","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemichi","family":"Watari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-1394","authenticated-orcid":false,"given":"Peixin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"issue":"3","key":"3998_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3998_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11912-016-0507-z","volume":"18","author":"V Rodriguez-Freixinos","year":"2016","unstructured":"Rodriguez-Freixinos V, Karakasis K, Oza AM. New targeted agents in endometrial cancer: are we really making progress? Curr Oncol Rep. 2016;18(4):23. https:\/\/doi.org\/10.1007\/s11912-016-0507-z.","journal-title":"Curr Oncol Rep"},{"issue":"24","key":"3998_CR3","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.3390\/cancers13246155","volume":"13","author":"A Gadducci","year":"2021","unstructured":"Gadducci A, Cosio S. Pharmacological treatment of advanced, persistent or metastatic endometrial cancer state of the art and perspectives of clinical research for the special issue \u201cdiagnosis and management of endometrial cancer.\u201d Cancers. 2021;13(24):6155. https:\/\/doi.org\/10.3390\/cancers13246155.","journal-title":"Cancers"},{"issue":"1","key":"3998_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-021-02018-1","volume":"40","author":"P Dong","year":"2021","unstructured":"Dong P, Xiong Y, Konno Y, Ihira K, Kobayashi N, Yue J, Watari H. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2\/miR-181a pathway. J Exp Clin Cancer Res. 2021;40(1):216. https:\/\/doi.org\/10.1186\/s13046-021-02018-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"3998_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1476-4598-10-99","volume":"10","author":"P Dong","year":"2011","unstructured":"Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer. 2011;10:99. https:\/\/doi.org\/10.1186\/1476-4598-10-99.","journal-title":"Mol Cancer"},{"issue":"7","key":"3998_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","volume":"45","author":"A Salmaninejad","year":"2016","unstructured":"Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N. Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest. 2016;45(7):619\u201340. https:\/\/doi.org\/10.1080\/08820139.2016.1197241.","journal-title":"Immunol Invest"},{"key":"3998_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.semcancer.2021.04.016","volume":"76","author":"C Fan","year":"2021","unstructured":"Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, Li Y. Cancer\/testis antigens: from serology to mRNA cancer vaccine. Semin Cancer Biol. 2021;76:218\u201331. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.016.","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"3998_CR8","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1158\/1078-0432.CCR-04-1702","volume":"11","author":"T Iwata","year":"2005","unstructured":"Iwata T, Fujita T, Hirao N, Matsuzaki Y, Okada T, Mochimaru H, Susumu N, Matsumoto E, Sugano K, Yamashita N, Nozawa S, Kawakami Y. Frequent immune responses to a cancer\/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer. Clin Cancer Res. 2005;11(10):3949\u201357. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-1702.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3998_CR9","first-page":"1063","volume":"23","author":"S Li","year":"2010","unstructured":"Li S, Meng L, Zhu C, Wu L, Bai X, Wei J, Lu Y, Zhou J, Ma D. The universal overexpression of a cancer testis antigen hiwi is associated with cancer angiogenesis. Oncol Rep. 2010;23(4):1063\u20138.","journal-title":"Oncol Rep"},{"issue":"9","key":"3998_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41389-018-0077-z","volume":"7","author":"JL King","year":"2018","unstructured":"King JL, Zhang B, Li Y, Li KP, Ni JJ, Saavedra HI, Dong JT. TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer. Oncogenesis. 2018;7(9):69. https:\/\/doi.org\/10.1038\/s41389-018-0077-z.","journal-title":"Oncogenesis"},{"issue":"1","key":"3998_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13048-021-00884-z","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhu K, Guan X, Xie S, Wang Y, Tong Y, Guo L, Zheng H, Lu R. TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer. J Ovarian Res. 2021;14(1):128. https:\/\/doi.org\/10.1186\/s13048-021-00884-z.","journal-title":"J Ovarian Res"},{"key":"3998_CR12","doi-asserted-by":"publisher","first-page":"4625123","DOI":"10.1155\/2020\/4625123","volume":"2020","author":"Q Yang","year":"2020","unstructured":"Yang Q, Yu B, Sun J. TTK, CDC25A, and ESPL1 as prognostic biomarkers for endometrial cancer. Biomed Res Int. 2020;2020:4625123. https:\/\/doi.org\/10.1155\/2020\/4625123.","journal-title":"Biomed Res Int"},{"issue":"24","key":"3998_CR13","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.21037\/atm-22-5783","volume":"10","author":"CH Cui","year":"2022","unstructured":"Cui CH, Wu Q, Zhou HM, He H, Wang Y, Tang Z, Zhang Y, Wang X, Xiao J, Zhang H. High tyrosine threonine kinase expression predicts a poor prognosis: a potential therapeutic target for endometrial carcinoma. Ann Transl Med. 2022;10(24):1352. https:\/\/doi.org\/10.21037\/atm-22-5783.","journal-title":"Ann Transl Med"},{"issue":"2","key":"3998_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.6004\/jnccn.2017.7066","volume":"16","author":"R Murali","year":"2018","unstructured":"Murali R, Delair DF, Bean SM, Abu-Rustum NR, Soslow RA. Evolving roles of histologic evaluation and molecular\/genomic profiling in the management of endometrial cancer. J Natl Compr Cancer Netw. 2018;16(2):201\u20139. https:\/\/doi.org\/10.6004\/jnccn.2017.7066.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"12","key":"3998_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"3998_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinform"},{"key":"3998_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinform"},{"issue":"7457","key":"3998_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cort\u00e9s ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CWM, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES, Getz G. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214\u20138. https:\/\/doi.org\/10.1038\/nature12213.","journal-title":"Nature"},{"issue":"11","key":"3998_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"19","key":"3998_CR20","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","volume":"32","author":"ZL Skidmore","year":"2016","unstructured":"Skidmore ZL, Wagner AH, Lesurf R, Campbell KM, Kunisaki J, Griffith OL, Griffith M. GenVisR: genomic visualizations in R. Bioinformatics. 2016;32(19):3012\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/btw325.","journal-title":"Bioinformatics"},{"issue":"4","key":"3998_CR21","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41. https:\/\/doi.org\/10.1186\/gb-2011-12-4-r41.","journal-title":"Genome Biol"},{"issue":"24","key":"3998_CR22","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, Teschendorff AE. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/btx513.","journal-title":"Bioinformatics"},{"issue":"5","key":"3998_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"3998_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinform"},{"issue":"4","key":"3998_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8(4):329-337.e4. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003.","journal-title":"Cell Syst"},{"issue":"13","key":"3998_CR26","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573-3587.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"issue":"12","key":"3998_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"issue":"6190","key":"3998_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suv\u00e0 ML, Regev A, Bernstein BE. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396\u2013401. https:\/\/doi.org\/10.1126\/science.1254257.","journal-title":"Science"},{"issue":"Database issue","key":"3998_CR29","doi-asserted-by":"publisher","first-page":"D816","DOI":"10.1093\/nar\/gkn673","volume":"37","author":"LG Almeida","year":"2009","unstructured":"Almeida LG, Sakabe NJ, deOliveira AR, Silva MC, Mundstein AS, Cohen T, Chen YT, Chua R, Gurung S, Gnjatic S, Jungbluth AA, Caballero OL, Bairoch A, Kiesler E, White SL, Simpson AJ, Old LJ, Camargo AA, Vasconcelos AT. CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res. 2009;37(Database issue):D816\u20139. https:\/\/doi.org\/10.1093\/nar\/gkn673.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3998_CR30","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1158\/1535-7163.MCT-18-1203","volume":"18","author":"SJ Anderhub","year":"2019","unstructured":"Anderhub SJ, Mak GW, Gurden MD, Faisal A, Drosopoulos K, Walsh K, Woodward HL, Innocenti P, Westwood IM, Naud S, Hayes A, Theofani E, Filosto S, Saville H, Burke R, van Montfort RLM, Raynaud FI, Blagg J, Hoelder S, Eccles SA, Linardopoulos S. High proliferation rate and a compromised spindle assembly checkpoint confers sensitivity to the MPS1 inhibitor BOS172722 in triple-negative breast cancers. Mol Cancer Ther. 2019;18(10):1696\u2013707. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-1203.","journal-title":"Mol Cancer Ther"},{"issue":"45","key":"3998_CR31","doi-asserted-by":"publisher","first-page":"19108","DOI":"10.1073\/pnas.0904343106","volume":"106","author":"A Janssen","year":"2009","unstructured":"Janssen A, Kops GJ, Medema RH. Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proc Natl Acad Sci USA. 2009;106(45):19108\u201313. https:\/\/doi.org\/10.1073\/pnas.0904343106.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46","key":"3998_CR32","doi-asserted-by":"publisher","first-page":"23132","DOI":"10.1073\/pnas.1915389116","volume":"116","author":"HC Fitzgerald","year":"2019","unstructured":"Fitzgerald HC, Dhakal P, Behura SK, Schust DJ, Spencer TE. Self-renewing endometrial epithelial organoids of the human uterus. Proc Natl Acad Sci USA. 2019;116(46):23132\u201342. https:\/\/doi.org\/10.1073\/pnas.1915389116.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3998_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/1541-7786.MCR-19-0561","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhao R, Chi S, Zhang W, Xiao C, Zhou X, Zhao Y, Wang H. UBE2C Is upregulated by estrogen and promotes epithelial\u2013mesenchymal transition via p53 in endometrial cancer. Mol Cancer Res. 2020;18(2):204\u201315. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0561.","journal-title":"Mol Cancer Res"},{"issue":"D1","key":"3998_CR34","doi-asserted-by":"publisher","first-page":"D950","DOI":"10.1093\/nar\/gkx1008","volume":"46","author":"G Zheng","year":"2018","unstructured":"Zheng G, Ma Y, Zou Y, Yin A, Li W, Dong D. HCMDB: the human cancer metastasis database. Nucleic Acids Res. 2018;46(D1):D950\u20135. https:\/\/doi.org\/10.1093\/nar\/gkx1008.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"3998_CR35","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.4161\/15384101.2014.962952","volume":"13","author":"J Bargiela-Iparraguirre","year":"2014","unstructured":"Bargiela-Iparraguirre J, Prado-Marchal L, Pajuelo-Lozano N, Jim\u00e9nez B, Perona R, S\u00e1nchez-P\u00e9rez I. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells. Cell Cycle. 2014;13(22):3590\u2013601. https:\/\/doi.org\/10.4161\/15384101.2014.962952.","journal-title":"Cell Cycle"},{"key":"3998_CR36","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.1038\/cddiscovery.2016.79","volume":"2","author":"MA Andonegui-Elguera","year":"2016","unstructured":"Andonegui-Elguera MA, C\u00e1ceres-Guti\u00e9rrez RE, Luna-Maldonado F, L\u00f3pez-Saavedra A, D\u00edaz-Ch\u00e1vez J, Cisneros-Soberanis F, Prada D, Mendoza-P\u00e9rez J, Herrera LA. BUB1 and SURVIVIN proteins are not degraded after a prolonged mitosis and accumulate in the nuclei of HCT116 cells. Cell Death Discov. 2016;2:16079. https:\/\/doi.org\/10.1038\/cddiscovery.2016.79.","journal-title":"Cell Death Discov"},{"issue":"6","key":"3998_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1158\/1535-7163.661.3.6","volume":"3","author":"EA Lee","year":"2004","unstructured":"Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, Kao GD. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol Cancer Ther. 2004;3(6):661\u20139.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"3998_CR38","first-page":"4854","volume":"11","author":"F Chen","year":"2018","unstructured":"Chen F, Wu P, Hu H, Tian D, Jiang N, Wu C. Protein kinase TTK promotes proliferation and migration and mediates epithelial\u2013mesenchymal transition in human bladder cancer cells. Int J Clin Exp Pathol. 2018;11(10):4854\u201361.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"3998_CR39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3892\/ol.2012.896","volume":"4","author":"X Qin","year":"2012","unstructured":"Qin X, Yan L, Zhao X, Li C, Fu Y. microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett. 2012;4(6):1290\u20136. https:\/\/doi.org\/10.3892\/ol.2012.896.","journal-title":"Oncol Lett"},{"issue":"5","key":"3998_CR40","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00428-021-03171-w","volume":"479","author":"K Sato","year":"2021","unstructured":"Sato K, Miyamoto M, Takano M, Tsuda H. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma. Virchows Arch. 2021;479(5):883\u201391. https:\/\/doi.org\/10.1007\/s00428-021-03171-w.","journal-title":"Virchows Arch"},{"issue":"1","key":"3998_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40246-021-00341-4","volume":"15","author":"X Lei","year":"2021","unstructured":"Lei X, Zhang M, Guan B, Chen Q, Dong Z, Wang C. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis. Hum Genom. 2021;15(1):39. https:\/\/doi.org\/10.1186\/s40246-021-00341-4.","journal-title":"Hum Genom"},{"key":"3998_CR42","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8403","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Zhou X, Liu J, Yin Y, Yuan X, Yang R, Wang Q, Ji J, He Q. Differentially expressed genes and key molecules of BRCA1\/2-mutant breast cancer: evidence from bioinformatics analyses. PeerJ. 2020;8: e8403. https:\/\/doi.org\/10.7717\/peerj.8403.","journal-title":"PeerJ"},{"issue":"10","key":"3998_CR43","doi-asserted-by":"publisher","first-page":"BSR20202711","DOI":"10.1042\/BSR20202711","volume":"40","author":"J Chen","year":"2020","unstructured":"Chen J, Wu R, Xuan Y, Jiang M, Zeng Y. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Biosci Rep. 2020;40(10):BSR20202711. https:\/\/doi.org\/10.1042\/BSR20202711.","journal-title":"Biosci Rep"},{"issue":"2","key":"3998_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4149\/neo_2021_210421N541","volume":"69","author":"YH Gao","year":"2022","unstructured":"Gao YH, Qu SS, Cao LQ, Yao M. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion. Neoplasma. 2022;69(2):274\u201382. https:\/\/doi.org\/10.4149\/neo_2021_210421N541.","journal-title":"Neoplasma"},{"issue":"1","key":"3998_CR45","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1080\/21655979.2021.1968778","volume":"12","author":"N Lu","year":"2021","unstructured":"Lu N, Ren L. TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer. Bioengineered. 2021;12(1):5759\u201368. https:\/\/doi.org\/10.1080\/21655979.2021.1968778.","journal-title":"Bioengineered"},{"key":"3998_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-030-73359-9_7","volume":"1330","author":"S Talukdar","year":"2021","unstructured":"Talukdar S, Chang Z, Winterhoff B, Starr TK. Single-cell RNA sequencing of ovarian cancer: promises and challenges. Adv Exp Med Biol. 2021;1330:113\u201323. https:\/\/doi.org\/10.1007\/978-3-030-73359-9_7.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"3998_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13249","volume":"55","author":"Z Yu","year":"2022","unstructured":"Yu Z, Zhang J, Zhang Q, Wei S, Shi R, Zhao R, An L, Grose R, Feng D, Wang H. Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. Cell Prolif. 2022;55(6): e13249. https:\/\/doi.org\/10.1111\/cpr.13249.","journal-title":"Cell Prolif"},{"issue":"1","key":"3998_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, Van Nieuwenhuysen E, Han S, Van den Broeck A, Coosemans A, Van Rompuy AS, Lambrechts D, Vergote I. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med. 2021;13(1):111. https:\/\/doi.org\/10.1186\/s13073-021-00922-x.","journal-title":"Genome Med"},{"key":"3998_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3389\/fonc.2019.01479","volume":"9","author":"N Panchy","year":"2020","unstructured":"Panchy N, Azeredo-Tseng C, Luo M, Randall N, Hong T. Integrative transcriptomic analysis reveals a multiphasic epithelial\u2013mesenchymal spectrum in cancer and non-tumorigenic cells. Front Oncol. 2020;9:1479. https:\/\/doi.org\/10.3389\/fonc.2019.01479.","journal-title":"Front Oncol"},{"issue":"4","key":"3998_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jb\/mvy047","volume":"164","author":"M Saitoh","year":"2018","unstructured":"Saitoh M. Involvement of partial EMT in cancer progression. J Biochem. 2018;164(4):257\u201364. https:\/\/doi.org\/10.1093\/jb\/mvy047.","journal-title":"J Biochem"},{"issue":"1","key":"3998_CR51","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/s41598-017-03972-7","volume":"7","author":"JH Tseng","year":"2017","unstructured":"Tseng JH, Bisogna M, Hoang LN, Olvera N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Levine DA, Jelinic P. miR-200c-driven mesenchymal-to-epithelial transition is a therapeutic target in uterine carcinosarcomas. Sci Rep. 2017;7(1):3614. https:\/\/doi.org\/10.1038\/s41598-017-03972-7.","journal-title":"Sci Rep"},{"issue":"2","key":"3998_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/2211536610666210604122816","volume":"10","author":"A Bouziyane","year":"2021","unstructured":"Bouziyane A, Lamsisi M, Benaguida H, Benhessou M, El Kerroumi M, Ennaji MM. Diagnostic value of microRNA 21 in endometrial cancer and benign lesions and its differential expression with clinicopathological parameters. Microrna. 2021;10(2):146\u201352. https:\/\/doi.org\/10.2174\/2211536610666210604122816.","journal-title":"Microrna"},{"issue":"7","key":"3998_CR53","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s10620-013-2612-2","volume":"58","author":"N Wang","year":"2013","unstructured":"Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X, Zang WQ, Li M, Ma YY, Wang T, Zhao GQ. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci. 2013;58(7):1863\u201370. https:\/\/doi.org\/10.1007\/s10620-013-2612-2.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3998_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115919","volume":"10","author":"SE Martin del Campo","year":"2015","unstructured":"Martin del Campo SE, Latchana N, Levine KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI, Carson M, Ganju A, Chan AN, Carson WE 3rd. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor. PLoS ONE. 2015;10(1): e0115919. https:\/\/doi.org\/10.1371\/journal.pone.0115919.","journal-title":"PLoS ONE"},{"issue":"2","key":"3998_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00404-017-4598-z","volume":"297","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Wang J, Wang X, Song W, Shi Y, Zhang L. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3. Arch Gynecol Obstet. 2018;297(2):433\u201342. https:\/\/doi.org\/10.1007\/s00404-017-4598-z.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"3998_CR56","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/jcmm.15911","volume":"26","author":"W Li","year":"2022","unstructured":"Li W, Song YY, Rao T, Yu WM, Ruan Y, Ning JZ, Yao XB, Yang SY, Cheng F. CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma. J Cell Mol Med. 2022;26(6):1729\u201341. https:\/\/doi.org\/10.1111\/jcmm.15911.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3998_CR57","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.3892\/ijmm.2018.3405","volume":"41","author":"J Chen","year":"2018","unstructured":"Chen J, Zhou C, Li J, Xiang X, Zhang L, Deng J, Xiong J. miR-21-5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med. 2018;41(4):1855\u201366. https:\/\/doi.org\/10.3892\/ijmm.2018.3405.","journal-title":"Int J Mol Med"},{"issue":"6","key":"3998_CR58","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.26355\/eurrev_202003_20687","volume":"24","author":"WX Qin","year":"2020","unstructured":"Qin WX, Shi Y, Zhu D, Li YP, Chen YH, Cui J, Cui GY, Pan JX, Ren ZY. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p. Eur Rev Med Pharmacol Sci. 2020;24(6):3204\u201314. https:\/\/doi.org\/10.26355\/eurrev_202003_20687.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3998_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/onc.2010.416","volume":"30","author":"D Frezzetti","year":"2011","unstructured":"Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, Bello AM, De Luca P, Calabrese C, Fusco A, Ceccarelli M, Zollo M, Barbacid M, Di Lauro R, De Vita G. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene. 2011;30(3):275\u201386. https:\/\/doi.org\/10.1038\/onc.2010.416.","journal-title":"Oncogene"},{"key":"3998_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.biopha.2018.05.047","volume":"104","author":"Z Li","year":"2018","unstructured":"Li Z, Yang L, Liu X, Nie Z, Luo J. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21. Biomed Pharmacother. 2018;104:181\u201392. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.047.","journal-title":"Biomed Pharmacother"},{"issue":"49","key":"3998_CR61","doi-asserted-by":"publisher","first-page":"85442","DOI":"10.18632\/oncotarget.20006","volume":"8","author":"H Xia","year":"2017","unstructured":"Xia H, Zhang W, Zhang B, Zhao Y, Zhao Y, Li S, Liu Y. miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro. Oncotarget. 2017;8(49):85442\u201351. https:\/\/doi.org\/10.18632\/oncotarget.20006.","journal-title":"Oncotarget"},{"issue":"12","key":"3998_CR62","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1073\/pnas.1700234114","volume":"114","author":"JM Mason","year":"2017","unstructured":"Mason JM, Wei X, Fletcher GC, Kiarash R, Brokx R, Hodgson R, Beletskaya I, Bray MR, Mak TW. Functional characterization of CFI-402257, a potent and selective Mps1\/TTK kinase inhibitor, for the treatment of cancer. Proc Natl Acad Sci USA. 2017;114(12):3127\u201332. https:\/\/doi.org\/10.1073\/pnas.1700234114.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"3998_CR63","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.bmc.2017.02.030","volume":"25","author":"Y Sugimoto","year":"2017","unstructured":"Sugimoto Y, Sawant DB, Fisk HA, Mao L, Li C, Chettiar S, Li PK, Darby MV, Brueggemeier RW. Novel pyrrolopyrimidines as Mps1\/TTK kinase inhibitors for breast cancer. Bioorg Med Chem. 2017;25(7):2156\u201366. https:\/\/doi.org\/10.1016\/j.bmc.2017.02.030.","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"3998_CR64","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12885-022-09899-1","volume":"22","author":"J Yu","year":"2022","unstructured":"Yu J, Gao G, Wei X, Wang Y. TTK protein kinase promotes temozolomide resistance through inducing autophagy in glioblastoma. BMC Cancer. 2022;22(1):786. https:\/\/doi.org\/10.1186\/s12885-022-09899-1.","journal-title":"BMC Cancer"},{"issue":"17","key":"3998_CR65","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jnci\/djt168","volume":"105","author":"BA Tannous","year":"2013","unstructured":"Tannous BA, Kerami M, Van der Stoop PM, Kwiatkowski N, Wang J, Zhou W, Kessler AF, Lewandrowski G, Hiddingh L, Sol N, Lagerweij T, Wedekind L, Niers JM, Barazas M, Nilsson RJ, Geerts D, De Witt Hamer PC, Hagemann C, Vandertop WP, Van Tellingen O, Noske DP, Gray NS, W\u00fcrdinger T. Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. J Natl Cancer Inst. 2013;105(17):1322\u201331. https:\/\/doi.org\/10.1093\/jnci\/djt168.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"3998_CR66","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI130435","volume":"130","author":"BC Chandler","year":"2020","unstructured":"Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver S, Thomas DG, Brown PH, Lawrence TS, Nyati S, Pierce LJ, Chinnaiyan A, Speers C. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. J Clin Invest. 2020;130(2):958\u201373. https:\/\/doi.org\/10.1172\/JCI130435.","journal-title":"J Clin Invest"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03998-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03998-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03998-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T03:03:30Z","timestamp":1677294210000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03998-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03998-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"8 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors are aware of and agree with the content of the paper and they are listed as co-authors of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}